Table 3.

Baseline characteristics, comorbidities and outcomes in patients from high risk country of origin for TB (> 100 cases per 100,000 population per year) comparing those not screened with screened for LTBI using QFG

		Not screened	Screened	Significance
Total		37	70
Gender	Male	17 (45.9%)	45 (64.3%)	0.07
	Female	20 (53.1%)	25 (35.7%)
Smoker	Never	26 (70.3%)	37 (52.5%)	0.31
	Former	8 (21.6%)	25 (35.7%)
	Current	2 (5.4%)	8 911.4%)
Age		71 ± 8	52 ± 11	< 0.01
Lung disease		3 (8.1%)	5 (7.1%)	0.86
Coronary disease		10 (27%)	15 (21.4%)	0.5
PVD		4 (10.8%)	10 (14.3)	0.61
CVD		4 (10.8%)	4 (5.7%)	0.34
Diabetes		25 (67.6%)	38 (54.3%)	0.18
IS		1 (2.7%)	5 (7.2%)	0.33
Cancer Diagnosis		3 (8.1%)	2 (2.9%)	0.22
Active TB	During study	0	1 (1.4%)	0.56
	Pre study	3 (8.1%)	3 (4.2%)
Death		10 (27%)	6 (8.7%)	0.01

Categorical variables used Pearson Chi Square test. Continuous variables used independent T test. A Levene’s test of equality of variances was conducted